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SYNTHESIS OF (2-FLUOROPHENYL)- AND (4-FLUOROPHENYL)-(2-NITROMETHYL)-
METHANONES AS PRECURSORS OF FLUORINATED PROSTANOIDS 
The synthesis of new fluorinated primary nitrocompounds − (2-fluorophenyl)- and (4-fluorophenyl)-
(2-nitromethylcyclopentyl)methanones has been realized by the nitromethane 1,4-addition to 1-
acylcyclopentenes, available by the reductive cleavage of corresponding cyclopent-5-en[d]isoxazolines. 
The obtained nitrocompounds are the precursors of new fluorinated prostaglandin analogues, which 
could be synthesized via the formation of second prostanoids side chain by nitrile oxides method. 
Introduction. Prostanoids along with acetoge-
nins, thromboxanes and others are the most impor-
tant forming in vivo products of fatty acids oxida-
tion [1]. High biological activity and participation 
of such compounds in regulation of various phy-
siological processes causes interest to their synthet-
ic analogues, which have more directed and pro-
longed action. It should be mentioned that more 
than 150 drugs among numerous pharmaceuticals 
sold all over the world are fluorinated compounds 
[2−4]. Thus synthesis of fluorinated analogues ac-
quires a particular importance since the introduc-
tion of fluorine atom  which is similar to hydrogen 
in size, on the one hand, does not lead to signifi-
cant change of molecules’ steric structure [5].  
On the other hand, substitution of hydrogen 
atoms by fluorine which possess high electron ne-
gativity can play a remarkable role in medical 
chemistry [2], particularly, causing improvement 
both of biological activity and stability of synthe-
sized compounds [3]. Consequently synthesis of 
fluorinated analogues of prostaglandins (PG) is of 
particular interest. Thus 18,19-didehydro-7,7-
difluoro-16-methyl PGI2 (AFP-07) possesses good 
metabolic stability while keeping a strong activity 
as an inhibitor of platelet adhesion [2]. Travoprost 
acts as a PGF receptor agonist and is used for glau-
coma treatment [2].  
The aim of this work is to realize the first stage 
in the scheme of construction of prostanoids 
second side chain in fluorinated enone synthons by 
nitrile oxides method.  
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Main part. In order to realize this task the in-
vestigation of the first stage of present scheme has 
been accomplished, namely nitromethane addition 
to enones 2а и 2b. The latest were received earlier 
by the reductive cleavage of corresponding cyclo-
pent-5-ene[d]isoxazolines 1а and 1b (scheme 1) [6].  
The Michael reaction was carried out at room 
temperature with stirring in dry nitromethane with 
tetramethylguanidine (TMG) until the initial enone 
would disappear. The reaction course monitoring 
was performed by analytic thin layer chromatogra-
phy (Scheme 2). 
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(a) X1 = F, X2 = H; (b) X1 = H, X2 = F  
Scheme 1  
Tetramethylguanidine plays role as a base 
which effects the activation of reagent (nitrome-
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thane). The purification of the products was per-
formed by preparative thin layer chromatography.  
As a result of the reaction the corresponding 
nitromethyl derivatives 3а (X1 = F, X2 = H) and 
3b (X1 = H, X2 = F) were prepared. Thus, the 
enone 2а was converted to nitromethyl derivative 
3а in 75.0% yield. Similarly the nitrocompound 
3b was obtained from synthon 2b in 47.4% yield. 
Within this research the formation of 1,2-adducts 
as well as of cis-isomers was not detected, which 
shows high chemo- and stereoselectivity of the 
reaction.  
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(a) X1 = F, X2 = H; (b) X1 = H, X2 = F  
Scheme 2 
The structure of obtained compounds was 
proved by means of modern spectral methods of 
organic compounds analysis: proton magnetic re-
sonance (PMR or 1Н NMR) and 13С nuclear mag-
netic resonance (13C NMR) spectroscopy.  
Thus, in 1Н NMR spectrum of nitrocompound 3а 
(Fig. 1) in comparison with initial enone 2а spec-
trum (Fig. 2) the signal of vinyl proton with chem-
ical shift 6.5 ppm disappears, while Н-12 signal
(PG atoms numeration is used for spectral data 
discussion) is shifted in high shielding field 
(2.99 ppm).  
There are observed signals of chemically non-
equivalent protons of nitromethyl group at 4.4 ppm, 
as well as Н-8 signal (2.73 ppm) along with the 
signals of aromatic protons and protons of cyclopen-
tane ring in spectrum of nitromethyl derivative 3а.  
Similar signals are detected in 1Н NMR spec-
trum of the product 3b.  
The structure of products of 1,4-addition of 
nitromethane to acylcyclopentenes is also proved 
by double resonance (spin decoupling), namely 
homonuclear decoupling experiments. Thus, the 
decoupling of CH2NO2 protons, simplified Н-12 
multiplet signal. These allowed to determine the 
Н-12 and Н-8 spin-spin coupling constant, which 
corresponded to relative trans-location of substi-
tuents in cyclopentane fragment. We have 
proved earlier trans-stereochemistry of Michael 
addition of nitromethane to similar enone syn-
thons [7]. Thus, the reaction proceeded with high 
stereoselectivity, as there wasn’t detected iso-
mers with relative cis-stereochemistry of acyl 
and nitromethyl substituents among the reaction 
products.  
As for 13С NMR spectra of synthesized com-
pounds the assignment of all signals to the corres-
ponding C-atoms of the suggested structure has 
been accomplished. Thus, 13С NMR spectrum of 
nitrocompound 3а (Fig. 3) in comparison with 
spectrum of the initial enone (Fig. 4) contains the 
signal of nitromethyl group carbon at 78.67 ppm 
while С-8 and С-12 signals are shifted in high field 
and are detected at 49.64 (С-8) and 31.67 ppm (С-
12). There are also signals of all other C-atoms of 
cyclopentane ring along with characteristic signals 
of carbonyl group (198.90 ppm) and п-fluorosub-
stituted benzene ring, for the latest being observed 
corresponding coupling constants due to spin-spin 
coupling with fluorine nuclei.  
 
 
Fig. 1. 1Н NMR spectrum of (4-fluorophenyl)-(2-nitromethylcyclopentyl)methanone 
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Fig. 2. 1Н NMR spectrum of (cyclopent-1-enyl)-(4-fluorophenyl)methanone   
 
Fig. 3. 13С NMR spectrum of (4-fluorophenyl)-(2-nitromethylcyclopentyl)methanone  
 
Fig. 4. 13С NMR spectrum of (cyclopent-1-enyl)-(4-fluorophenyl)methanone 
Experimental part. 1Н and 13С NMR spectra 
of substances solutions in СDCl3 with hexamethyl-
disiloxane (HMDS) as internal standard were rec-
orded on Bruker AVANCE spectrometer 
(400 MHz).  The reaction course was monitored by 
thin layer chromatography (TLC) on silica gel 
plates Kieselgel 60 F254 (Merck), the eluent being 
ether – light petroleum, developer: iodine or 4% 
KMnO4 solution. The used solvents were purified 
according to standard procedures [8]. 
The following atoms numeration has been used 
for spectral data discussion:  
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Michael 1,4-addition of nitromethane to 
(cyclopent-1-enyl)-(4-fluorophenyl)- and (cyclo-
pent-1-enyl)-(2-fluorophenyl)methanone. Tetra-
methylguanidine (5 drops) was added to a stirred 
solution of enone (0.46 mmol) in dry nitromethane 
(5 ml). Then the reaction mixture was stirred at 
room temperature until disappearance of the initial 
enone. The reaction proceeding control was carried 
out by analytic TLC. Then the reaction mixture 
was filtered through silica gel, which was eluted 
additionally by benzene, after that solvent was dis-
tilled under reduced pressure. The product was 
separated from the obtained residue by preparative 
TLC (eluent: ether – hexane). 
(4-Fluorophenyl)-(2-nitromethylcyclopentyl)-
methanone was prepared in 75.0% yield as an oil.  
1Н NMR spectrum, δ, ppm (J, Hz): 7.96 dd 
(2Н; Нar-2 + Нar-6; J = 9.0); 7.12 dd (2Н; Нar-3 + 
Нar-5; J1 = 8.7; J2 = 8.4); 4.42 m (2Н; CH2NO2; J1 = 
= 12.5; J2 = 7.4; J3 = 6. 9); 3.56 m (1Н; Н-8; J1 = 
= 7.4; J2 = 7.2); 3.27 m (1Н; H-12; J1 = 9.0; J2 = 
= 7.4; J3 = 7.2); 2.19 m (1Н; HA-9; J1 = 12.5; J2 = 
= 8.2; J3 = 7.4); 2.09 m (1Н, HA-11; J1 = 12.3; J2 = 
= 7.4); 1.75 m (3Н, HB-9 + 2H-10; J1 = 12.5; J2 = 
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= 12.3; J3 = 7.2); 1.52 m (1Н, НB-11; J1 = 12.5; J2 = 
= 8.2).  
13С NMR spectrum, δ, ppm (J, Hz): 198.90 
(С=О); 165.79 (J = 255; С−F); 132.60 (J = 3; Сar-1); 
131.07 (J = 10; Сar-2 + Сar-6); 115.85 (J = 22;  
Сar-3 + Car-5); 78.67 (CH2NO2); 49.64 (С-8); 39.78 
(С-11); 31.67 (С-12); 30.01 (С-9); 24.52 (С-10).  
 
(2-Fluorophenil)-(2-nitromethylcyclopentyl)-
methanone was prepared in 47.4% yield as an oil.  
1Н NMR spectrum, δ, ppm (J, Hz): 7.81 m 
(1Н; Нar-6; J1 = 7.7; J2 = 1.8); 7.52 m (1Н; Нar-4; J1 = 
=7.2; J2 = 1.8); 7.23 m (1Н; Нar-5; J1 = 7.7; J2 = 
= 1.0); 7.11 dd (1Н; Нar-3; J1 = 8.4; J2 = 1.0); 
4.48 dd (1Н; CHANO2; J1 = 12.0; J2 = 6.7); 4.39 dd 
(1Н; CHBNO2); J1 = 12.0; J2 = 7.7); 3.49 m (1H; H-
8; J1 = 7.9; J2 = 6.7); 3.26 m (1H; H-12; J1 =  
= 7.9; J2 = 7.4); 2.18 m (1Н; HA-9; J1 = 12.0; J2 = 
= 8.4); 2.6 m (1Н, HA-11; J1 = 12.3; J2 = 7.7); 1.76 m 
(3Н, HB-9 + СН2-10; J1 = 13.5; J2 = 5.6); 1.49 m 
(1Н, HB-11; J1 = 12.8; J2 = 8.2).  
13С NMR spectrum, δ, ppm (J, Hz): 199.25 (J = 
= 9; С=О); 161.39 (J = 253; С−F); 134.60 (J = 9; 
Сar-4); 130.87 (J = 2; Сar-6); 125.36 (J = 12; Сar-1); 
124.59 (J = 4; Сar-4); 116.63 (J = 23; Car-3); 78.91 
(CH2NO2); 54.23 (J = 7; С-8); 39.77 (С-12); 30.43 
(С-11); 30.17 (С-9); 24.24 (С-10).  
 
Conclusion. Thus, the following results were 
obtained in this research:  
− synthesis of fluorinated primary nitro-
compounds as nitrile oxides precursors in the 
scheme of second PG side chain formation by ni-
trile oxides method was realized; 
− Michael reaction proceeded with high che-
mo- and stereoselectively;  
− new possibilities of nitrile oxides technology 
employment in the synthesis of complex natural 
compounds analogues were demonstrated. 
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